There is new information out for patients taking the blood thinner Pradaxa. A recent court update shows the number of lawsuits alleging the drug caused internal injuries or death has risen nearly 30 percent in recent months.
Pradaxa is a blood thinner approved by the Food and Drug Administration (FDA) in 2010 as a stroke preventative for patients with atrial fibrillation.
The Institute for Safe Medication Practices has warned that patients may be nearly five times as likely to die from Pradaxa bleeding than from bleeding with warfarin, a traditional blood thinning medication. A study this year from the Netherlands suggests patients taking newer blood thinners like Pradaxa may be 55 percent more likely to suffer internal bleeding.
A growing number of patients have filed Pradaxa lawsuits alleging internal bleeding, leading to the consolidation of cases in a federal multidistrict litigation court in Illinois. The latest court records show that the number of cases filed has increased from 1,133 on July 10 to 1,470 by September 11, a rise of nearly 30 percent in two months.
Large pharmaceutical companies have a team of attorneys and unlimited resources to defend any action brought against them. Drug manufacturers must exercise reasonable care in the labeling, manufacturing conditions and dissemination of vital information to medical doctors and pharmacists concerning the risks of their products. Serious incidents can occur as the result of taking an improperly manufactured drug or medication that causes serious adverse reactions. Injures can range from physical disabilities, organ failure, birth defects to even death.
Anyone affected by internal bleeding after taking Pradaxa should speak with a lawyer about their legal options. To schedule a consultation with someone from our firm, do not hesitate to contact our injury attorneys at 305-476-7400 today. We handle cases throughout the nation and around the globe.
Colson Hicks Eidson – Injury Attorneys